Roche Walks Away From HOOKIPA Pharma-Partnered KRAS-Focused Cancer Deal
HOOKIPA Pharma's strategic focus on HB-200 program for HPV16+ HNSCC, infectious disease cure collaboration with Gilead, and recent developments.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers OneMedNet (NASDAQ:ONMD) stock rose 172.1% to $1.39 during Monday’s pre-market session. The market value of their outstanding…
AbbVie, Arch Capital, Gilead Sciences And A Telecom Giant On CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Rob Sechan of NewEdge Wealth said Gilead Sciences, Inc.
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Jin Medical International (NASDAQ:ZJYL) shares moved upwards by 94.4% to $137.0 during Monday’s regular session. The market…
Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and warrant attention.
Nasdaq Gains 100 Points; CarMax Earnings Top Views
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday.
The Dow traded up 0.37% to 37,218.15 while the NASDAQ rose 0.73% to 14,885.76. The S&P 500 also rose, gaining, 0.50% to 4,721.72.
Why CarMax Shares Are Trading Higher By Around 8%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 73.2% to $0.98 during Thursday’s regular session. The market value…
Crude Oil Moves Lower; Micron Issues Strong Forecast
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Thursday.
The Dow traded up 0.58% to 37,296.40 while the NASDAQ rose 0.77% to 14,891.87. The S&P 500 also rose, gaining, 0.68% to 4,730.26.
Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?
Gilead Sciences Inc (NASDAQ: GILD) announced on Thursday that it has purchased 15 million shares of HOOKIPA Pharma Inc (NASDAQ: HOOK) for approximately $21.25 million,